CIPREC

Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aire C1119ACN

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed